Escitalopram
- Product NDC
- 51672-1348
- 11-digit product format
- 516721348
- Labeler code
- 51672
- Product ID
- 51672-1348_38e51a59-5806-77a6-e063-6394a90af6c6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Escitalopram Oxalate
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA079121
- Marketing category
- ANDA
- Marketing start
- 2012-05-03
- Substance
- ESCITALOPRAM OXALATE
- Active strength
- 5 mg/5mL
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Escitalopram
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ESCITALOPRAM OXALATE | 5 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5U85DBW7LO |
| Rxcui | 351285 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Escitalopram Oxalate | ACTIVE INGREDIENT | 5U85DBW7LO | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
| Escitalopram | ACTIVE MOIETY | 4O4S742ANY | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
| citric acid monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
| malic acid | INACTIVE INGREDIENT | 817L1N4CKP | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
| propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
| sodium citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
| sorbitol | INACTIVE INGREDIENT | 506T60A25R | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51672-1348 | ESCITALOPRAM (ESCITALOPRAM OXALATE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 6 package rows | 20210703_c871d3fe-5ca2-410c-976d-9ec4b72c878f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51672-1348-1 | 51672134801 | 1 BOTTLE in 1 CARTON (51672-1348-1) / 240 mL in 1 BOTTLE | 1 bottle | 2012-05-03 | 0000-00-00 | No | No | Current |
| 51672-1348-8 | 51672134808 | 1 BOTTLE in 1 CARTON (51672-1348-8) / 120 mL in 1 BOTTLE | 1 bottle | 2012-05-03 | 0000-00-00 | No | No | Current |
| 51672-1348-9 | 51672134809 | 1 BOTTLE in 1 CARTON (51672-1348-9) / 480 mL in 1 BOTTLE | 1 bottle | 2012-05-03 | 0000-00-00 | No | No | Current |